Redefining Innovation Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry
Auteurs : Kansal Ruchin, Huth Jeff
Most people marvel at the level of innovation demonstrated by the biopharmaceutical industry in bringing new products to the market ? especially in the past 20 years. However, there is a crisis looming in the industry that should be a concern to all of us who take for granted the constant pace at which new treatments, and increasingly cures, have emerged from the laboratories of current sector incumbents. In the book, we examine the evolution of the biopharmaceutical industry to understand how it became what we term a "unicorn industry" with a unique, US-centered business model that has led to multiple blockbuster products (aka, unicorns) year after year. We explore how past success has created perceived barriers to innovation diversification beyond the chemical or biological-based biopharmaceutical product, and highlight the warning signs of the industry?s decline. We define a potential pathway for transforming the industry?s business model by broadening the definition, sources, and enablers of innovation beyond the traditional biopharmaceutical product. We introduce and advocate for the 80-80 Rule - "Being 80% confident that you will only be 80% right the first time should feel normal." The 80-80 Rule is a theme that emphasizes speed and willingness to embrace uncertainty and overcome internal barriers to change. It sets the standard for redefining innovation as a platform to reignite growth of the biopharmaceutical industry.
Reviews
Setting the Context
Foreword
Preface
Acknowledgments
The 80-80 Rule
Section I REDEFINING INNOVATION
1 Rise of a Unicorn Industry
2 The Unicorn Industry Loses Its Wings
3 An Experiment in Challenging the Status Quo
4 Innovation Redefined
5 Next-Generation Unicorn Industry
Section II IGNITING GROWTH
6 Applying "The 80-80 Rule"
7 Setting Up for Success
8 Finding White Spaces
9 Developing New Ventures
10 Becoming Adept at Partnering
11 Afterword
Index
Date de parution : 09-2021
15.6x23.4 cm
Date de parution : 05-2018
15.6x23.4 cm
Thèmes de Redefining Innovation :
- généralités - encyclopédies, annuaires médicaux
- Économies et politiques économiques mondiales : relations économiques internationales / douanes, exportation
- Santé publique / médecine du sport / médecine légale
- Matériel médical / instrumentation / biomatériaux
- direction / stratégie d'entreprise
- qualité / gestion de production - maintenance
- généralités sur l'informatique.
- gestion des hôpitaux, cliniques et maisons médicalisées
Mots-clés :
Pay For Performance; Largest Pharmacy Benefit Managers; Personal Health Records; Biopharmaceutical Industry; Open Study Designs; RESPIMAT Inhaler; Northwell Health; Revenue Equilibrium; White Spaces; Biopharma Industry; Leadership Foresight; Geisinger Health System; Healthcare Ecosystem; Gdp Investment; Biopharma Companies; Durham Humphrey Amendment; Biopharmaceutical Product; Hatch Waxman Act; Boehringer Ingelheim; Chief Experience Officer; Clinical Decision Support Systems; Corporate Venture Capital; Biopharmaceutical Product Development; Good Life; Related Healthcare Costs